Target intelligence / Profile preview

RNA, U6 small nuclear 1096, pseudogene (RNU6-1096P)

Target
RNU6-1096P
Molecular classification
Pseudogene, Small nuclear RNA (snRNA) pseudogene, Non-coding RNA
01

Overview

RNU6-1096P (RNA, U6 small nuclear 1096, pseudogene) is a pseudogene derived from the U6 small nuclear RNA (snRNA) family, annotated as a non-coding RNA and classified as a pseudogene in the human genome[2]. U6 snRNA itself is an essential component of the spliceosome, the molecular machinery responsible for splicing pre-mRNA in eukaryotes[1][3][5]. However, pseudogenes like RNU6-1096P do not encode functional RNA or protein products and typically arise through gene duplication or retrotransposition events. While some RNA pseudogenes have regulatory roles through RNA interference or competing for microRNAs, there is no direct evidence or functional characterization for RNU6-1096P in cellular or disease contexts[4][2]. Thus, RNU6-1096P is not considered a therapeutic target and there is nothing to suggest it is directly involved in known biological pathways or disease processes.

Other names
RNU6-1096PRNA U6 small nuclear 1096 pseudogeneU6 snRNA pseudogene
02

Mechanism of action

Not applicable

03

Biological functions

No direct biological function; pseudogenes can have regulatory functions such as acting as competing endogenous RNAs (ceRNAs), antisense RNAs, or sources of small interfering RNAs (siRNAs), but there is no specific evidence for RNU6-1096P itself
04

Disease associations

None established; some pseudogenes are implicated in cancer and other diseases generally as regulatory RNAs, but no specific disease role is documented for RNU6-1096P

Beyond the preview

Go deeper on RNA, U6 small nuclear 1096, pseudogene (RNU6-1096P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1096, pseudogene (RNU6-1096P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call